Relationship Between Sonic Hedgehog Protein, Brain-Derived Neurotrophic Factor and Oxidative Stress in Autism Spectrum Disorders
Open Access
- 9 October 2011
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 37 (2) , 394-400
Abstract
The etiology of autism spectrum disorders (ASD) is not well known but oxidative stress has been suggested to play a pathological role. We report here that the serum levels of Sonic hedgehog (SHH) protein and brain-derived neurotrophic factor (BDNF) might be linked to oxidative stress in ASD. By using the whole blood or polymorphonuclear leukocytes, we demonstrated that autistic children produced a significantly higher level of oxygen free radicals (OFR). In addition, we found significantly higher levels of serum SHH protein in children with mild as well as severe form of autism. We also found that the serum level of BDNF was significantly reduced in autistic children with mild form of the disorder but not with severe form of the disorder. Our findings are the first to report a correlation between SHH, BDNF and OFR in autistic children, suggesting a pathological role of oxidative stress and SHH in autism spectrum disorders.Keywords
This publication has 31 references indexed in Scilit:
- Sonic hedgehog improves delayed wound healing via enhancing cutaneous nitric oxide function in diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Sonic hedgehog mediates BDNF-induced neuroprotection against mitochondrial inhibitor 3-nitropropionic acidBiochemical and Biophysical Research Communications, 2009
- Paradoxical dysregulation of the neural stem cell pathway sonic hedgehog‐gli1 in autoimmune encephalomyelitis and multiple sclerosisAnnals of Neurology, 2008
- Recruitment of the Sonic hedgehog signalling cascade in electroconvulsive seizure‐mediated regulation of adult rat hippocampal neurogenesisEuropean Journal of Neuroscience, 2005
- Communicating with HedgehogsNature Reviews Molecular Cell Biology, 2005
- Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegenerationMolecular Therapy, 2004
- Mini ReviewGrowth Factors, 2004
- Intrastriatal Injection of Sonic Hedgehog Reduces Behavioral Impairment in a Rat Model of Parkinson's DiseaseExperimental Neurology, 2002
- Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leukocytes and carrageenan-induced rat's paw oedemaInternational Journal of Immunopharmacology, 1992
- Oxygen free‐radicals and lipid peroxidation: inhibition by the protein caeruloplasminFEBS Letters, 1980